- Novel Coronavirus
-
Drug Discovery Services
- Antiviral Drug Discovery
- Complement Therapy
- SARS-CoV-2 Aptamers
- Antisense Oligonucleotides
- Protease Inhibitors
- Inhibitor of Host Cell Protease
- Abelson Kinase Inhibitors
- RNA Synthesis Inhibitors
- Nucleoside Analogue
- Neuraminidase Inhibitors
- Neutralizing Antibody
- Antiviral Peptide
- Broad-spectrum Antiviral Drug
- Anti-Inflammatory Drugs
- High-Throughput Screening
- Vaccine Discovery
- Evaluation Platforms for SARS-CoV-2 Drugs
- Antiviral Drug Discovery
- IVD Immunoassays
- Products
- Resources
- About Us
Nitazoxanide (CAT#: Vinh-007SX)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| Vinh-007SX |
|
For Research Use Only. We do not provide direct services or products for patients.
- Product Overview
- O-[N-(5-Nitrothiazol-2-yl)carbamoyl]phenyl acetate; NTZ
- Target
- SARS-CoV-2
- Molecular Formula
- C12H9N3O5S
- Molecular Weight
- 307.3 g/mol
- Purity
- >98% by HPLC
- Storage
- Store at -20°C.
- Introduction
- Nitazoxanide is a broad-spectrum synthetic benzamide compound that is used as medicine for the treatment of various helminthic, protozoal, and viral infections. In-vitro analysis suggests that this compound inhibits replication of many members of the coronavirus family including MERS-Cov, BCoV, HECoV, and improves clinical outcomes by suppressing the overproduction of pro-inflammatory cytokines which is observed in patients with coronavirus infection. The clinical implications of this compound on SARS-CoV-2 is under investigation at the moment.
Online Inquiry
For Research Use Only. We do not provide direct services or products for patients.
For Research Use Only. We do not provide direct services or products for patients.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.